FORWARD PHARMA
Forward Pharma is a privately held biotechnology company focused on the immunomodulatory compound dimethyl fumarate and derivatives, for applications as a pharmaceutical drug product to treat immune disorders such as multiple sclerosis and psoriasis. Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark, in the heart of Medicon Valley. Since 2007 we have also operated out of a subsidiary, Forward Pharma GmbH, in Leipzig, Germany, and since August 2014 out of a subsidiary in the United States, Forward Pharma USA, LLC.
FORWARD PHARMA
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2005-01-01
Address:
Copenhagen, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.forward-pharma.com
Total Employee:
11+
Status:
Active
Contact:
+45 33 44 42 42
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress Apache Euro Microsoft Exchange Online Office 365 Mail
Current Advisors List
Current Employees Featured
Stock Details
Official Site Inspections
http://www.forward-pharma.com
- Host name: linux135.unoeuro.com
- IP address: 94.231.103.148
- Location: Denmark
- Latitude: 55.7123
- Longitude: 12.0564
- Timezone: Europe/Copenhagen
More informations about "Forward Pharma"
Forward Pharma - The Org
Forward Pharma A/S is a Danish biopharmaceutical company that commenced development in 2005 of a proprietary formulation of DMF for the treatment of inflammatory and neurological …See details»
Investors – Forward Pharma
Forward Pharma A/S is a Danish biopharmaceutical company that from 2005 to 2017 developed a proprietary formulation of DMF for the treatment of inflammatory and neurological indications. …See details»
Forward Pharma - businessabc.net
Feb 25, 2025 Forward Pharma was founded in 2000 with the mission of developing innovative therapies to improve the lives of patients suffering from autoimmune and inflammatory …See details»
Forward Pharma A/S
Forward Pharma A/S Østergade 24 A, 1., DK-1100 København K Annual Report for 1 January - 31 December 2021 CVR No28 86 58 80 The Annual Report was presented and adopted at the Annual General Meeting of the Company on 20/5 2022 Frederik B. Hasling Chairman of the General Meeting DocuSign Envelope ID: 96861E1E-520E-40D6-A59D-BE5F636A8B6DSee details»
Forward Pharma - VentureRadar
Forward Pharma (Shenzhen Forward Pharmaceutical Co., Ltd) is a national high-tech enterprise dedicated to international innovative drug research and development in oncology and …See details»
Our Company-FORWARD PHARMA
Forward Pharma wins new honor of "SRDI Small- & Medium-Sized Enterprise" December 16, 2022. Forward Pharma Wins 7.75 Million Award From Shenzhen Government Funds. View All News; Contact Us. Telephone: (0755) 8634 4960. Corporate Office. Shenzhen Address: Room 406, Block B, 19 GaoxinSee details»
Forward Pharma - Funding, Financials, Valuation & Investors
Venture Round - Forward Pharma . 2: obfuscated. obfuscated. Optical Valley Venture Capital, Wuhan Hi-Tech: Jul 14, 2023: Series B - Forward Pharma . 1: obfuscated. obfuscated. ZGC …See details»
Forward Pharma A/S - VentureRadar
Forward Pharma A/S is a Danish biopharmaceutical company that commenced development in 2005 of a proprietary formulation of DMF for the treatment of inflammatory and neurological …See details»
Organigramm Forward Pharma - The Official Board
Organizational Chart of Forward Pharma. Forward Pharma www.forward-pharma.com +45 3344 4242; Führungskraft hinzufügen. Forward Pharma Nachrichten . Fehlt etwas? Wir suchen …See details»
Forward Pharma GmbH - Drug pipelines, Patents, Clinical trials
Explore Forward Pharma GmbH with its drug pipeline, therapeutic area, technology platform, 7 clinical trials. Explore Forward Pharma GmbH with its drug pipeline, therapeutic area, …See details»
Forward Pharma - Teams - The Org
Forward Pharma. Teams; Teams at Forward Pharma +2. Board of Directors. 5 members. Leadership Team. 1 members. The Org helps you hire great candidates. It takes less than ten …See details»
Forward Pharma - Crunchbase Company Profile & Funding
Forward Pharma is a privately held biotechnology company focused on the immunomodulatory compound dimethyl fumarate and derivatives, for applications as a pharmaceutical drug …See details»
Forward Pharma Company Profile | Industry Research and Analysis …
Forward Pharma is a Danish biopharmaceutical company specializing in the research, development, and commercialization of ALS (Amyotrophic Lateral Sclerosis) and MS (Multiple …See details»
Forward Pharma Company Profile - Office Locations, Competitors …
Forward Pharma has 5 employees at their 1 location. See insights on Forward Pharma including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Forward Pharma A/S - Drug pipelines, Patents, Clinical trials
Explore Forward Pharma A/S with its drug pipeline, therapeutic area, technology platform, 7 clinical trials, 7 news, Drug:FP-237, FP-219, FP-289.See details»
Forward Pharma - Products, Competitors, Financials, Employees ...
Oct 15, 2014 Forward Pharma is a biopharmaceutical company that develops proprietary formulations aimed at treating inflammatory and neurological conditions. The company's …See details»
Forward Pharma
Forward Pharma A/S is a Danish biopharmaceutical company that from 2005 to 2017 developed a proprietary formulation of DMF for the treatment of inflammatory and neurological indications. …See details»
Forward Pharma | Startup Profile and Investments - Bounce Watch
Forward Pharma, Pioneering new therapies in oncology and autoimmunity through advanced small-molecule pharmaceuticals and targeted antibody drugs. Established in 2015, the …See details»
Organization: Forward Pharma LEI 54930057YYF35PR5NQ33
Forward Pharma. Information about the issuer. News and credit ratings. (LEI 54930057YYF35PR5NQ33). Tables with accounting and financial reporting.See details»
Management (former) – Forward Pharma
Prior to joining Forward Pharma in 2015, he held positions of increasing seniority in the Danish pharmaceutical company Novo Nordisk A/S, including roles of Global Medical Director for Victoza® (liraglutide) and for Saxenda® in its regulatory and pre-launch phase for weight management, supporting a successful FDA advisory committee meeting and finally FDA and …See details»